Skip to main content

Published locations for IL-23 antibody risankizumab can effect, maintain remission in Crohn’s

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IL-23 antibody risankizumab can effect, maintain remission in Crohn’s

User login

  • Reset your password
  • /content/il-23-antibody-risankizumab-can-effect-maintain-remission-crohns
  • /clinicianreviews/article/140174/gastroenterology/il-23-antibody-risankizumab-can-effect-maintain
  • /familypracticenews/article/140174/gastroenterology/il-23-antibody-risankizumab-can-effect-maintain
  • /gihepnews/article/140174/gastroenterology/il-23-antibody-risankizumab-can-effect-maintain-remission
  • /internalmedicinenews/article/140174/gastroenterology/il-23-antibody-risankizumab-can-effect-maintain
  • /internalmedicine/article/140174/gastroenterology/il-23-antibody-risankizumab-can-effect-maintain
  • /familymedicine/article/140174/gastroenterology/il-23-antibody-risankizumab-can-effect-maintain